Your browser doesn't support javascript.
loading
A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer.
Takada, Masahiro; Imoto, Shigeru; Ishida, Takanori; Ito, Yoshinori; Iwata, Hiroji; Masuda, Norikazu; Mukai, Hirofumi; Saji, Shigehira; Ikeda, Takafumi; Haga, Hironori; Saeki, Toshiaki; Aogi, Kenjiro; Sugie, Tomoharu; Ueno, Takayuki; Ohno, Shinji; Ishiguro, Hiroshi; Kanbayashi, Chizuko; Miyamoto, Takeshi; Hagiwara, Yasuhiro; Toi, Masakazu.
Affiliation
  • Takada M; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Imoto S; Department of Breast Surgery, Kyorin University School of Medicine, Mitaka, Japan.
  • Ishida T; Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Ito Y; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Masuda N; Department of Breast and Endocrine Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Mukai H; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Saji S; Department of Medical Oncology, Fukushima Medical University, Fukushima, Japan.
  • Ikeda T; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Haga H; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
  • Saeki T; Breast Oncology Service, Saitama Medical University International Medical Center, Hidaka, Japan.
  • Aogi K; Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
  • Sugie T; Breast Surgery, Kansai Medical University Hospital, Hirakata, Japan.
  • Ueno T; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ohno S; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ishiguro H; Breast Oncology Service, Saitama Medical University International Medical Center, Hidaka, Japan.
  • Kanbayashi C; Department of Breast Oncology, Niigata Cancer Center Hospital, Niigata, Japan.
  • Miyamoto T; Department of Breast Oncology, Gunma Prefectural Cancer Center, Ota, Japan.
  • Hagiwara Y; Department of Biostatistics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Toi M; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. masakazu_toi@tmhp.jp.
Breast Cancer Res Treat ; 202(3): 485-496, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37676450
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Breast Cancer Res Treat Year: 2023 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Breast Cancer Res Treat Year: 2023 Type: Article Affiliation country: Japan